Trade-Ideas LLC identified

Cigna

(

CI

) as a pre-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Cigna as such a stock due to the following factors:

  • CI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $360.2 million.
  • CI traded 12,997 shares today in the pre-market hours as of 8:14 AM.
  • CI is down 8.4% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CI with the Ticky from Trade-Ideas. See the FREE profile for CI NOW at Trade-Ideas

More details on CI:

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through three segments: Global Health Care, Global Supplemental Benefits, and Group Disability and Life. The stock currently has a dividend yield of 0%. CI has a PE ratio of 18. Currently there are 7 analysts that rate Cigna a buy, 1 analyst rates it a sell, and 5 rate it a hold.

The average volume for Cigna has been 1.8 million shares per day over the past 30 days. Cigna has a market cap of $35.9 billion and is part of the health care sector and health services industry. The stock has a beta of 0.30 and a short float of 1% with 0.67 days to cover. Shares are down 5.6% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Cigna as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income.

Highlights from the ratings report include:

  • Despite its growing revenue, the company underperformed as compared with the industry average of 11.8%. Since the same quarter one year prior, revenues slightly increased by 4.4%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • The current debt-to-equity ratio, 0.41, is low and is below the industry average, implying that there has been successful management of debt levels.
  • CIGNA CORP' earnings per share from the most recent quarter came in slightly below the year earlier quarter. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, CIGNA CORP increased its bottom line by earning $8.04 versus $7.82 in the prior year. This year, the market expects an improvement in earnings ($9.29 versus $8.04).
  • Net operating cash flow has increased to $894.00 million or 34.63% when compared to the same quarter last year. Despite an increase in cash flow, CIGNA CORP's average is still marginally south of the industry average growth rate of 35.30%.
  • The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. Compared to other companies in the Health Care Providers & Services industry and the overall market, CIGNA CORP's return on equity exceeds that of both the industry average and the S&P 500.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.